OcellO B.V. is a privately owned contract research organisation, which was founded in November 2011 based on technology developed at Leiden University.
OcellO is an innovative biotech company offering CRO services for the drug discovery industry that can significantly improve the efficiency of lead development. OcellO excels in the development of clinically relevant in vitro human micro-tissue models that can be used for the screening and profiling of small molecules and biologics. The analysis of these models, many of which use patient-derived material, is enabled by OcellO’s unique high throughput 3D imaging and phenotypic profiling technology. As well as providing measurements of cell growth and viability, phenotypic profiling allows the measurement of more complex biology that better correlates with clinical endpoints. Furthermore, compounds with the optimum therapeutic profile or optimum target specific profile can be selected to enable a better ranking of compounds at early stage in the drug development process.
Picture by Palladium Photodesign
Ask your questions or request an introductory call
Find us here
J.H. Oortweg 21
2333 CH Leiden
Email [email protected]
Telephone +31 (0)71 3322 875
Chamber of Commerce
(KvK) number: 53055926